Adhansia XR vs. Mydayis

Reviewed on 1/27/2021

Are Adhansia XR and Mydayis the Same Thing?

Adhansia XR (methylphenidate hydrochloride) and Mydayis (mixed salts of a single-entity amphetamine product) are central nervous system (CNS) stimulants used to treat Attention Deficit Hyperactivity Disorder (ADHD).

Adhansia XR is used to treat ADHD in patients 6 years and older and Mydayis is used to treat ADHD in patients 13 years and older.

Side effects of Adhansia XR and Mydayis that are similar include insomnia, dry mouth, decreased appetite, and weight loss.

Side effects of Mydayis that are different from Adhansia XR include irritability, nausea, increased heart rate, anxiety, feeling jittery, tooth grinding, depression, diarrhea, palpitations, menstrual pain or cramping, and erectile dysfunction.

Both Adhansia XR and Mydayis may interact with monoamine oxidase inhibitors (MAOIs) and medications to treat excess stomach acid.

Mydayis may also interact with acidifying or alkalinizing agents (GI and urinary), selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors (SNRIs), triptans, antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, St. John's wort, quinidine, and ritonavir.

Withdrawal symptoms may occur if you suddenly stop taking Mydayis.

What Are Possible Side Effects of Adhansia XR?

Common side effects of Adhansia XR include:

  • insomnia,
  • dry mouth,
  • decreased appetite, and
  • weight loss

What Are Possible Side Effects of Mydayis?

Common side effects of Mydayis include:

  • insomnia,
  • decreased appetite,
  • decreased weight,
  • irritability,
  • nausea,
  • dry mouth,
  • increased heart rate,
  • anxiety,
  • feeling jittery,
  • tooth grinding,
  • depression,
  • diarrhea,
  • palpitations,
  • menstrual pain or cramping, and
  • erectile dysfunciton.

Central nervous system stimulants, including Mydayis, have a high potential for abuse and dependence./

QUESTION

Who is at greater risk for developing ADHD? See Answer

What Is Adhansia XR?

Adhansia XR (methylphenidate hydrochloride) is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older. Adhansia XR is available in generic form.

What Is Mydayis?

Mydayis is a central nervous system stimulant prescription medicine. It is used for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD). Mydayis may help increase attention and decrease impulsiveness and hyperactivity in patients with ADHD.

Mydayis (mixed salts of a single-entity amphetamine product) extended-release capsules are a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 13 years and older.

What Drugs Interact With Adhansia XR?

Adhansia XR may interact with monoamine oxidase inhibitors (MAOIs) and medications to treat excess stomach acid. Tell your doctor all medications and supplements you use.

What Drugs Interact With Mydayis?

Mydayis may interact with acidifying or alkalinizing agents (GI and urinary), monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors (SNRIs), triptans, antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, St. John's wort, quinidine, ritonavir, omeprazole, esomeprazole, pantoprazole, and cimetidine. Tell your doctor all medications and supplements you use.

How Should Adhansia XR be Taken?

The recommended starting dose of Adhansia XR for patients 6 years and older is 25 mg once daily in the morning. The dosage of Adhansia XR may be increased in increments of 10 to 15 mg at intervals of at least 5 days.

How Should Mydayis be Taken?

The recommended starting dose of Mydayis for adults and children 13 to 17 years is 12.5 mg.

SLIDESHOW

ADHD Symptoms in Children See Slideshow
Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

References
Adlon Therapeutics L.P. Adhansia XR Product Information.

adhansiaxr-hcp.com

Takeda. Mydayis Product Information

https://www.mydayis.com/

Health Solutions From Our Sponsors